Page 642 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 642

Index  627


             Frame shift mutations, 190   Hematopoietic cells, 112     Hyperplastic polyps, 412
             Free radicals, 11            Hematopoietic system, 285    Hypersensitivity pneumonitis, 373
             Fulminant hepatic failure, 432  Hemochromatosis, 27, 436–437  Hypersensitivity, 93t
             Functions of liver, 421      Hemolytic anemia, 303          Arthus reaction, 100
                                            extrinsic/extracorpuscular   type, I, 97–98
                                               abnormalities, 303t       type II, 99–100
             G                              intrinsic/intracorpuscular   type III, 100–101
             G6PD (glucose-6-phosphate         abnormalities, 303t       type IV, 102–103
                dehydrogenase) enzyme, 306–307  Hemophilia, 348–349    Hypersplenism, 345
             Galactosemia, 202            Hemosiderin, 26–27           Hypertension, 245–250
             Gallstones, 445–448          Hemostasis, 345–347            benign hypertension, 245
             Gangrene, 13, 14, 17           common pathway, 347f         benign nephrosclerosis, 249
             Gangrenous necrosis, 14        extrinsic pathway, 346f      essential (primary) hypertension, 246
             Gastric carcinoma, 401–403     intrinsic pathway, 346f      malignant hypertension, 245
             Gastritis, 396               Hemozoin, 27                   malignant nephrosclerosis, 249–250
             Gastrointestinal stromal tumour, 403  Hepatocyte growth factor/scatter    secondary hypertension, 246
             Gastroesophageal reflux disease, 393  factor, 57t         Hyperthyroidism, 535
             Genetic heterogeneity, 191   Hepatitis                    Hypertrophic osteoarthropathy, 146
             Germ cell tumours, 491         HAV, 426                   Hypertrophy, 5–6
             Gestational trophoblastic disease,    HBV, 426            Hypochromic anemias, 293
                519–520                     HCV, 428                   Hypoparathyroidism, 551–552
               choriocarcinoma, 521t        Chronic, 430
               H. mole, 521t                HDV, 428
             Ghon focus, 158, 160           HEV, 428                   I
             Giant cells, 52              Hepatoma, 443–444            Idiopathic thrombocytopenic purpura,
             Gilbert syndrome, 425        Hepatoma/Hepatocellular carcinoma,   347–348
             Glial fibrillary acidic protein, 148  443                 IgA nephropathy (Berger’s disease), 474
             Glioblastoma multiforme, 620  Hereditary coagulation disorders, 348  Immature teratoma, 494
             Glitter cells, 614           Hereditary spherocytosis, 305–306  Immunity, 89
             Glomerular syndromes, 463    Herpes simplex infection, 172–173  Immunohistochemistry, 147
             Glycogenoses, 197, 205t      Hexosaminidase, 203          Immunologic tolerance, 105–106
             Glycosuria, 460              Heyman antigen, 464          Infarct, 83
             Glycosyl-phosphatidylinositol (GPI)   HIV-associated nephropathy, 472  red, 83
                protein, 313              High-density lipoprotein, 114, 212, 241   renal, 84
             Good Pasture syndrome, 108, 229,   High molecular weight kininogen, 2  white, 83
                464, 466, 467             HLA complex, 94f             Infectious mononucleosis, 170–171
             Goiter, 541–543              Hodgkin’s lymphoma (HL), 332–334  Inferior vena caval syndrome, 236
             Gorlin syndrome, 140, 609      Reed’Sternberg (RS) cells, 332–333  Inflammation, 31
             Gouty arthritis, 598–599     Homans sign, 236               acute, 34–35
             Gram-negative bacteria, 35, 85, 154,   Homeostasis, 2       cardinal signs, 31
                155, 175                  Horner syndrome, 382           chronic, 47
             Gram-positive bacteria, 151  Homer–Wright rosettes, 586   Inflammatory bowel disease, 407–408
             Granuloma pyogenic, 251      Homocystinuria, 202            Crohn’s disease, 408–409
             Granulosa cell tumour of ovary, 512  Howell’Jolly bodies, 288–290t  ulcerative colitis, 409
             Granulation tissue, 52       HPV, 144                     Inflammatory polyps, 411
             Granulocytopenia, 315        Human chorionic gonadotrophins, 491  Inhibitors of angiogenesis, 141
             Granulomatous inflammation, 50–51  Humoral immunity, 90   Innate immunity, 91
             Graves, disease, 535–537     Humoral rejection, 112       Insudation hypothesis, 242
             Gray (Gy), 215               Hurthle cell, 544            Insulin, 558
             Growth factors (GFs), 57     Hutchinson’s teeth, 168      Interferons, 57t
             Gumma, 51                    Hyaline change, 24           Interleukins, 57t
             GVHD, 113                    Hydatidiform mole, 519       Intermediate filament, 437
             Gynaecomastia, 533             Complete, 520              Intestinal tuberculosis, 406
                                            Partial, 520               Intratubular germ cell neoplasi
                                          Hydronephrosis, 488              (ITGCN), 491
             H                            Hydroperoxyeicosatetranoic acid, 40  Intravascular hemolysis, 304
             Hairy cell leukemia, 342–343  Hydropic/vacuolar degeneration, 22  Intrinsic asthma, 366
             Hamartoma, 124               Hydrostatic pressure, 69     Inversion, 192
             Hansen disease, 161          Hyperaldosteronism, 553–554  Involucrum, 572
             Hamartomatous polyps, 411–412  primary, 553               Ionizing radiation, 215–216
             Healing by primary or first    secondary, 553               chronic effects of radiation, 216
                intention, 62             Hyperemia, 72                  Hazards of radiation, 215
             Healing by secondary intention, 64  Hyperbilirubinaemia, 421, 425  Iron-deficiency anemia, 295
             Heart failure, 281–284       Hyperlipidemia, 241          Iron metabolism, 290–292
             Heart failure cells or siderophages, 74  Hyperparathyroidism, 549  Ischemic heart disease, 256
             Heat shock proteins, 30        primary hyperparathyroidism, 549
             Heberden’s nodes, 594          secondary hyperparathyroidism, 551
             Heinz’s bodies, 288–290t       tertiary hyperparathyroidism, 551  J
             Helicobacter pylori, 145       water clear cells, 550     Jaundice, 423–425
             Helper T cells, 95           Hyperplasia, 5               Juvenile polyps, 411




                                  mebooksfree.com
   637   638   639   640   641   642   643   644   645